上皮-间质转换
博莱霉素
肺纤维化
白藜芦醇
波形蛋白
纤维化
TLR4型
癌症研究
信号转导
NF-κB
下调和上调
化学
氧化应激
肺
特发性肺纤维化
炎症
药理学
免疫学
病理
医学
内科学
免疫组织化学
生物化学
化疗
基因
作者
Lei Wang,Mei Shao,Wei Jiang,Yangfeng Huang
出处
期刊:Tissue & Cell
[Elsevier BV]
日期:2022-10-07
卷期号:79: 101953-101953
被引量:23
标识
DOI:10.1016/j.tice.2022.101953
摘要
Pulmonary fibrosis (PF) is a difficult clinical condition with no effective treatment and a high mortality rate. Patients usually die of respiratory failure. In the present, we hypothesized that resveratrol (Res) could suppress bleomycin (BLM)-induced PF in rats and examined the detailed mechanism.The successfully established BLM-induced PF rat models and normal healthy rats were randomly assigned into the control, model, Res-low, Res-medium, and Res-high groups. The extent of PF in rats was determined by Masson and H&E staining. ELISA was used to detect changes in the inflammatory factors IL-1β, IL-6, TNF-α, SOD, and GSH-PX in lung tissue. Microscopic lung fibrosis scoring was done using the Ashcroft scale. Western blotting and RT-qPCR assays were used to analyze the effects of Res on the epithelial-mesenchymal transition (EMT).The administration of Res ameliorated the BLM-induced PF in vivo. Res could inhibit pro-inflammatory factors and regulates oxidative stress levels. It also revealed that Res downregulated Vimentin and upregulated E-cadherin expression. Res inhibited fibrosis and inflammatory responses in rat lung tissue. The activation of the TLR4/NF-κB and TGF-β1/smad3 signaling pathways were inhibited following Res treatment.The present study suggested that Res may protect against BLM-induced PF by inhibiting the EMT and down-regulating the TLR4/NF-κB and TGF-β1/smad3 signaling pathways.
科研通智能强力驱动
Strongly Powered by AbleSci AI